The Brief Transprejudice Scale: Development and Validation
Group Processes & Intergroup Relations · 12.11.2026
DOI: 10.1177/13684302261499271 ↗Kurz gefasst
Fachartikel in der Zeitschrift Group Processes & Intergroup Relations, online erschienen am 12.11.2026. Verfasst von Diana Cheso und 3 weiteren Autor:innen. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In recent years, research on predictors of transprejudice has increased, yet existing psychometric measures of the construct have limitations, including outdated terminology, conflation of gender atypicality with trans identity and a lack of multidimensional structure. We report on the development and validation of the Brief Transprejudice Scale (BTS), a concise yet multifaceted measure of transprejudice. In Study 1 ( N = 341), exploratory factor analysis and Rasch analysis were used to refine an initial item pool, resulting in a three-factor (negative affect, category exclusion and moralism) 14-item scale . In Study 2 ( N = 391), confirmatory factor analysis supported this factor structure, and validity tests demonstrated the scale’s strong concurrent, convergent and divergent validity. Despite its brevity, this new scale provides a psychometrically sound and efficient tool that allows researchers to capture multiple aspects of transprejudice.
Zitieren
APA
Cheso, D., Bjornsdottir, R. T., McKay, R., & ka, H. Z. (2026). The Brief Transprejudice Scale: Development and Validation. Group Processes & Intergroup Relations. https://doi.org/10.1177/13684302261499271
Vancouver
Cheso D, Bjornsdottir RT, McKay R, ka HZ. The Brief Transprejudice Scale: Development and Validation. Group Processes & Intergroup Relations. 2026. doi:10.1177/13684302261499271
BibTeX
@article{Cheso2026,
author = {Cheso, Diana and Bjornsdottir, R. Thora and McKay, Ryan and ka, Hanna Zagef},
title = {The Brief Transprejudice Scale: Development and Validation},
journal = {Group Processes & Intergroup Relations},
year = {2026},
doi = {10.1177/13684302261499271}
}
EUVIMED